Option Care Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Option Care Health (OPCH).

Price Target Range — 12 Quarters

Analyst Consensus — 12 Analysts

2S.Buy

7Buy

3Hold

Consensus RatingBuy# Analysts12Avg. Consensus PT$31Upside to Avg. PT+0.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 30, 2026	Deutsche Bank	Pito Chickering	Downgrade	Buy→Hold	$26→$24
Jul 17, 2026	Stephens & Co.	Raj Kumar	Downgrade	Overweight→Equal-Weight	$30→$24
Jun 8, 2026	Goldman Sachs	Scott Fidel	Initiate	Neutral	$22
May 6, 2026	Morgan Stanley	Erin Wright	PT Cut	Overweight	$485
May 4, 2026	JP Morgan	Lisa Gill	PT Cut	Overweight	$40→$33
May 1, 2026	Barrington Research	Michael Petusky	PT Cut	Outperform	$42→$32
May 1, 2026	UBS	A.J. Rice	PT Cut	Buy	$45→$39
May 1, 2026	TD Cowen	Charles Rhyee	PT Cut	Hold	$37→$23
Jan 16, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$38→$42
Jan 13, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$35→$38
Jan 13, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$36→$38
Dec 11, 2025	Stephens & Co.	Raj Kumar	Initiate	Overweight	$40
Dec 9, 2025	B of A Securities	Kevin Fischbeck	PT Raise	Buy	$32→$35
Dec 9, 2025	Deutsche Bank	Pito Chickering	PT Raise	Buy	$31→$36
Nov 3, 2025	TD Cowen	Charles Rhyee	PT Cut	Hold	$30→$27
Oct 31, 2025	Citizens	Constantine Davides	PT Cut	Market Outperform	$38→$36
Oct 31, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$38
Oct 17, 2025	Morgan Stanley	Erin Wright	Initiate	Overweight	$35
Oct 2, 2025	TD Cowen	Charles Rhyee	Initiate	Hold	$30
Sep 23, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$38

More with Benzinga EdgeGet Access

Analyst Ratings News

McKesson Takes A Stake In Option Care — With An Option On The Rest

CD&R and McKesson acquire Option Care Health in a $5.8 billion transaction at $32.05 per share as analysts assess acquisition terms.

Vandana Singh

PRO
Deutsche Bank Downgrades Option Care Health to Hold, Lowers Price Target to $24

Deutsche Bank analyst Pito Chickering downgrades Option Care Health (NASDAQ:OPCH) from Buy to Hold and lowers the price target from $26 to $24.

Benzinga Newsdesk

PRO
Stephens & Co. Downgrades Option Care Health to Equal-Weight, Lowers Price Target to $24

Stephens & Co. analyst Raj Kumar downgrades Option Care Health (NASDAQ:OPCH) from Overweight to Equal-Weight and lowers the price target from $30 to $24.

Benzinga Newsdesk

PRO
Goldman Sachs Initiates Coverage On Option Care Health with Neutral Rating, Announces Price Target of $22

Goldman Sachs analyst Scott Fidel initiates coverage on Option Care Health (NASDAQ:OPCH) with a Neutral rating and announces Price Target of $22.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Option Care Health, Lowers Price Target to $28

Morgan Stanley analyst Erin Wright maintains Option Care Health (NASDAQ:OPCH) with a Overweight and lowers the price target from $38 to $28.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Option Care Health, Lowers Price Target to $33

JP Morgan analyst Lisa Gill maintains Option Care Health (NASDAQ:OPCH) with a Overweight and lowers the price target from $40 to $33.

Benzinga Newsdesk

Option Care Health Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Option Care Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

McKesson Takes A Stake In Option Care — With An Option On The Rest

PRO
Deutsche Bank Downgrades Option Care Health to Hold, Lowers Price Target to $24

PRO
Stephens & Co. Downgrades Option Care Health to Equal-Weight, Lowers Price Target to $24

PRO
Goldman Sachs Initiates Coverage On Option Care Health with Neutral Rating, Announces Price Target of $22

PRO
Morgan Stanley Maintains Overweight on Option Care Health, Lowers Price Target to $28

PRO
JP Morgan Maintains Overweight on Option Care Health, Lowers Price Target to $33

People Also Watch

People Also Watch

Option Care Health Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Option Care Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

McKesson Takes A Stake In Option Care — With An Option On The Rest

PRODeutsche Bank Downgrades Option Care Health to Hold, Lowers Price Target to $24

PROStephens & Co. Downgrades Option Care Health to Equal-Weight, Lowers Price Target to $24

PROGoldman Sachs Initiates Coverage On Option Care Health with Neutral Rating, Announces Price Target of $22

PROMorgan Stanley Maintains Overweight on Option Care Health, Lowers Price Target to $28

PROJP Morgan Maintains Overweight on Option Care Health, Lowers Price Target to $33

People Also Watch

People Also Watch

PRO
Deutsche Bank Downgrades Option Care Health to Hold, Lowers Price Target to $24

PRO
Stephens & Co. Downgrades Option Care Health to Equal-Weight, Lowers Price Target to $24

PRO
Goldman Sachs Initiates Coverage On Option Care Health with Neutral Rating, Announces Price Target of $22

PRO
Morgan Stanley Maintains Overweight on Option Care Health, Lowers Price Target to $28

PRO
JP Morgan Maintains Overweight on Option Care Health, Lowers Price Target to $33